Literature DB >> 10633054

Control of an outbreak of respiratory syncytial virus infection in immunocompromised adults.

B L Jones1, S Clark, E T Curran, S McNamee, G Horne, B Thakker, J Hood.   

Abstract

Respiratory syncytial virus (RSV) is increasingly recognized as an important pathogen in immunocompromised adults, particularly those receiving bone marrow transplants, and, given the ease with which it spreads, represents a significant nosocomial problem. We describe an outbreak of RSV infection involving eight patients on a haematology/oncology ward which was controlled by early screening of patients and staff. Positive patients were cohort nursed on a separate ward and basic infection control measures including use of gowns and gloves were enforced. Children under age 12 were denied ward access. All patients with lower respiratory tract infection, and bone marrow transplant recipients with upper respiratory symptoms, were treated with nebulized ribavirin. There were no deaths. We conclude that awareness of the risk of RSV infection in immunocompromised patients coupled with rapid diagnosis and treatment, screening of symptomatic patients and staff, cohort nursing of cases and basic infection control procedures can prevent spread of RSV infection and reduce morbidity. Copyright 2000 The Hospital Infection Society.

Entities:  

Mesh:

Year:  2000        PMID: 10633054     DOI: 10.1053/jhin.1999.0666

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  7 in total

Review 1.  Nosocomial spread of viral disease.

Authors:  C Aitken; D J Jeffries
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

2.  A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections.

Authors:  John V Williams; Rodrigo Martino; Núria Rabella; Magdalena Otegui; Rocio Parody; Joshua M Heck; James E Crowe
Journal:  J Infect Dis       Date:  2005-08-12       Impact factor: 5.226

3.  Molecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unit.

Authors:  Hamid Jalal; David F Bibby; Julie Bennett; Rebecca E Sampson; Nicola S Brink; Stephen MacKinnon; Richard S Tedder; Katherine N Ward
Journal:  J Clin Microbiol       Date:  2007-03-28       Impact factor: 5.948

4.  Contributing and Terminating Factors of a Large RSV Outbreak in an Adult Hematology and Transplant Unit.

Authors: 
Journal:  PLoS Curr       Date:  2014-09-19

Review 5.  Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies.

Authors:  Fareed Khawaja; Roy F Chemaly
Journal:  Haematologica       Date:  2019-06-20       Impact factor: 9.941

6.  Consecutive yearly outbreaks of respiratory syncytial virus in a haemato-oncology ward and efficacy of infection control measures.

Authors:  T Inkster; K Ferguson; A Edwardson; R Gunson; R Soutar
Journal:  J Hosp Infect       Date:  2017-05-06       Impact factor: 3.926

Review 7.  Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology.

Authors:  Marie von Lilienfeld-Toal; Annemarie Berger; Maximilian Christopeit; Marcus Hentrich; Claus Peter Heussel; Jana Kalkreuth; Michael Klein; Matthias Kochanek; Olaf Penack; Elke Hauf; Christina Rieger; Gerda Silling; Maria Vehreschild; Thomas Weber; Hans-Heinrich Wolf; Nicola Lehners; Enrico Schalk; Karin Mayer
Journal:  Eur J Cancer       Date:  2016-09-25       Impact factor: 9.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.